Cingulate

Cingulate Treasury Stock

The Treasury Stock of Cingulate (CING) as of Nov 11, 2026 is 134.88 M USD. In the previous year, Treasury Stock was 115.94 M USD — a change of 16.33% (higher).

Treasury Stock

134.88 MUSD

YoY

16.33%

Last updated:

Treasury Stock of Cingulate is 2025 134.88 M USD. Treasury Stock of Cingulate was 2024 115.94 M USD. It decreases by 16.33% higher compared to the previous year.

The Cingulate Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2019
32.00 USD
Jan 1, 2020
31.02 M USD
Jan 1, 2021
72.57 M USD
Jan 1, 2022
73.29 M USD
Jan 1, 2023
86.07 M USD
Jan 1, 2024
115.94 M USD
Jan 1, 2025
134.88 M USD
The Cingulate Treasury Stock history
YEARTreasury StockYoY
134.88 MUSD+16.33%
115.94 MUSD+34.70%
86.07 MUSD+17.44%
73.29 MUSD+0.99%
72.57 MUSD+133.94%
31.02 MUSD+96.94 M%
32.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cingulate Stock analysis

What does Cingulate do? Cingulate Inc is a US-based biopharmaceutical company headquartered in Kansas City, Kansas, that focuses on the development, manufacturing, and commercialization of pharmaceutical products. The firm utilizes its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles designed to improve the lives of patients suffering from commonly diagnosed conditions. The company specifically targets the treatment of attention deficit/hyperactivity disorder (ADHD) through its innovative approach to drug delivery. The firm is currently developing two lead product candidates, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). These drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. By employing this technology, Cingulate Inc aims to provide effective treatment options for ADHD across three core patient segments: children aged 6-12, adolescents aged 13-17, and adults aged 18 and older. Cingulate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cingulate stock

Treasury Stock of Cingulate is 134.88 M USD in 2025.

Treasury Stock of Cingulate changed from 115.94 M USD to 134.88 M USD, representing a 16.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Cingulate since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Cingulate historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cingulate

All Key Metrics — Cingulate